First update in a century in testing drugs for elemental impurities

Aug 21, 2013

For the first time in more than 100 years, drug and dietary supplement manufacturers are updating the tests used to ensure that their products contain safe levels of metal impurities, and the stringent new requirements, instruments and costs are the topic of the cover story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.

Ann Thayer, C&EN senior correspondent, explains that in 1905, the nonprofit standards-setting U.S. Pharmacopeial Convention (USP) first introduced a method for checking medicines for arsenic, mercury and other heavy metals, which can be harmful to health. That same method remains in use today. After almost 20 years of discussion, USP in February published new limits on 15 such and procedures for measuring the levels.

Although implementation has been delayed, makers of the instruments needed for the new tests are working with drug companies to prepare for the new era. Depending on the number of products to be analyzed, companies may need to install multiple systems at multiple sites. Some large companies have dozens of sites globally, and each could require one test system that costs up to $150,000.

The article is titled "Trace Metals Debate."

Explore further: Rooting out horse-meat fraud in the wake of a recent food scandal

More information: cen.acs.org/articles/91/i33/Tr… e-Metals-Debate.html

add to favorites email to friend print save as pdf

Related Stories

Reducing gene-damaging impurities in medicines

Sep 29, 2010

Drug manufacturers have been adjusting to strict new government standards that limit the amount of potentially harmful impurities in medicine, according to the cover story of the current issue of Chemical & Engineering News ...

Chemical company giants stall with global economy

Jul 31, 2013

The world's 50 largest chemical companies—with combined 2012 sales of almost $1 trillion and products that touch the lives of people everywhere—are the topic of the cover story in the current edition of Chemical & En ...

Microdosing: Updating its role in developing new medicines

Jan 23, 2013

One of yesterday's most promising new tools for speeding the development of new medicines—"microdosing"—has found niches in that process today, and they include uses unanticipated a decade ago. That topic, an update on ...

Welcome to the new era of University, Inc.

Aug 07, 2013

After years of wariness, universities and industry scientists are forging new partnerships that are reinvigorating academic science departments, preparing students for careers and giving corporations better access to fundamental ...

Recommended for you

New chip promising for tumor-targeting research

3 hours ago

(Phys.org) —Researchers have developed a chip capable of simulating a tumor's "microenvironment" and plan to use the new system to test the effectiveness of nanoparticles and drugs that target cancer.

New star-shaped molecule breakthrough

9 hours ago

(Phys.org) —Scientists at The University of Manchester have generated a new star-shaped molecule made up of interlocking rings, which is the most complex of its kind ever created.

A refined approach to proteins at low resolution

Sep 19, 2014

Membrane proteins and large protein complexes are notoriously difficult to study with X-ray crystallography, not least because they are often very difficult, if not impossible, to crystallize, but also because ...

User comments : 0